Topic Briefing

Healthcare Policy

Executive Summary

The healthcare sector is grappling with a federal crackdown on Medicare Advantage upcoding and PBM secrecy, triggering a $100 billion market correction for major insurers. Simultaneously, the FDA and ASTP are modernizing clinical trial and data exchange standards to accelerate product delivery and dismantle long-standing silos in diagnostic imaging.

Key Takeaways

  • Prepare for a 2027 revenue squeeze in Medicare Advantage: CMS proposed keeping reimbursement rates nearly flat (0.09% increase) and restricting the "chart reviews" that insurers use to boost payments via upcoding. Source
  • New Labor Department rules will force PBMs to disclose drug rebates and fees, potentially saving employers and workers $1 billion annually by exposing historically hidden prescription drug data. Source
  • Veeva Systems is challenging Epic Systems' employment covenants in court, arguing that Epic’s non-compete lists and equity repurchase programs facially violate Wisconsin labor statutes. Source
  • The United States officially completed its withdrawal from the World Health Organization on January 22, 2026, signaling a pivot toward bilateral health partnerships and private sector-led global health efforts.

Key Themes

Major trends and developments identified from this week's coverage

Data Interoperability and Modernization

Federal agencies are dismantling information silos and modernizing data baselines (USCDI v7) to facilitate the exchange of complex diagnostic images and clinical records.

3 articles

Managed Care Accountability and Transparency

Insurers and PBMs face intensifying scrutiny over billing practices, with CMS and the Labor Department proposing rules to curb upcoding and hidden fees.

3 articles

Regulatory Innovation and Flexibility

The FDA is introducing flexibilities in manufacturing (CMC) for cell and gene therapies and modernizing statistical methods to speed rare disease treatments to market.

3 articles

Key Players

Top companies, people, and technologies mentioned this week

Epic
Company●●●●●

2 articles

Acquired by Health Gorilla, Acquired by State of Texas

KFF Health News
Company●●●●●

3 articles

Child of KFF, Collaborates with Johns Hopkins Bloomberg School of Public Health

U.S. Food and Drug Administration
Company●●●●●

3 articles

Child of Department of Health and Human Services, Child of U.S. Department of Health and Human Services

CMS
Company●●●●●

3 articles

Collaborates with Immigration and Customs Enforcement, Collaborates with Office of the National Coordinator for Health Information Technology

FDA
Company●●●●●

2 articles

Child of HHS, Child of U.S. Department of Health and Human Services

CDC
Company●●●●●

2 articles

Collaborates with Ginkgo Biosecurity, Collaborates with North Carolina Department of Health and Human Services

Food and Drug Administration
Company●●●●●

3 articles

Child of Department of Health and Human Services, Child of U.S. Department of Health and Human Services

Marty Makary
Person●●●●●

4 articles

Works with FDA, Works with Food and Drug Administration

Mehmet Oz
Person●●●●●

2 articles

Works with Centers for Medicare & Medicaid Services, Works with Centers for Medicare & Medicaid Services (CMS)

Centers for Medicare & Medicaid Services
Company●●●●●

2 articles

Child of Department of Health and Human Services, Created by CMS-Aligned Network

Regulatory & Policy Updates

Technology & Innovation

ASTP proposed USCDI version 7 with new health data classes

Version 7 transitions away from incremental updates, incorporating diagnostic imaging elements that will become the federal baseline for certified health IT.

FDA ImportShield Program cut product review times by 66%

Consolidated regional teams into a centralized operation to better identify counterfeit medications and contaminated food at ports of entry.

ASTP issued RFI to eliminate CD/DVD reliance for diagnostic imaging exchange

Addressing the PACS-EHR silo aims to move imaging data into standard FHIR-based interoperability workflows, ending patient reliance on physical media.

Market & Competitive Intelligence

UnitedHealth Group

Market Entry

UnitedHealth Group lost $62.4 billion in market capitalization in one day following the CMS proposal for nearly flat Medicare Advantage rate increases for 2027.

Health Gorilla

Partnership

Health Gorilla retained Quinn Emanuel to defend against Epic’s litigation, joining Particle Health and CureIS in a legal front that may pursue affirmative counterclaims against Epic's governance.

Medicare Part D

Funding

Gross Medicare Part D spending on GLP-1 drugs reached $27.5 billion in 2024, a five-fold increase since 2019, driven by surged utilization for type 2 diabetes.

What to Watch

Expanded Medicare Obesity Coverage

2026-2027 launch

The BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) model will begin expanding obesity drug coverage for Medicaid in 2026 and Medicare in 2027.

CDC Grant Restructuring

Immediate and ongoing review expected

CDC briefly paused $5 billion in public health grants for alignment review; watch for potential restructuring of future grant cycles to favor administration priorities like biosecurity.

Raw Ingredient Supply Chain Oversight

Ongoing investigation through 2026

The ByHeart infant formula botulism outbreak (51 infants sickened) has been linked to powdered whole milk; expect increased FDA oversight of dairy-based raw ingredients.

Editor's Picks

AI-recommended articles based on relevance and quality

Want personalized briefings?

Kelp creates AI-powered briefings tailored to your specific interests and sources. Get the insights that matter most to you.

Start Your Free Briefing